About Drug Development Solutions
Drug Development Solutions is a company based in Ely (United Kingdom) founded in 1982 was acquired by Resolian in July 2022.. Drug Development Solutions offers products and services including LC-MS/MS, Immunoassay, Flow Cytometry, and Drug Metabolism Analysis. Drug Development Solutions operates in a competitive market with competitors including Eurofins Scientific, WuXi AppTec, Ipsen, CHEPLAPHARM and ANI Pharmaceuticals, among others.
- Headquarter Ely, United Kingdom
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Resolian Inc.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Drug Development Solutions
Drug Development Solutions offers a comprehensive portfolio of products and services, including LC-MS/MS, Immunoassay, Flow Cytometry, and Drug Metabolism Analysis. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Mass spectrometry service for analyzing small molecules in drug testing
Testing method for detecting biomarkers in therapeutics
Technique for cell analysis in research applications
Services for pharmacokinetics and toxicity studies
Funding Insights of Drug Development Solutions
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Drug Development Solutions
Drug Development Solutions has secured backing from 1 investor. Prominent investors backing the company include Resolian. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Biologics drug development and bioanalytic services are offered.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Drug Development Solutions
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Drug Development Solutions
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Drug Development Solutions Comparisons
Competitors of Drug Development Solutions
Drug Development Solutions operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Eurofins Scientific, WuXi AppTec, Ipsen, CHEPLAPHARM and ANI Pharmaceuticals, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Laboratory testing and contract research services are provided globally.
|
|
| domain | founded_year | HQ Location |
Provider of CRO and CDMO services
|
|
| domain | founded_year | HQ Location |
Biopharmaceutical company focused on developing and commercializing innovative treatments in oncology, rare disease, and neuroscience to improve patient health outcomes
|
|
| domain | founded_year | HQ Location |
Branded pharmaceutical products are developed, marketed, and distributed globally.
|
|
| domain | founded_year | HQ Location |
Branded and generic prescription drugs are developed, manufactured, and marketed.
|
|
| domain | founded_year | HQ Location |
CRO focused on clinical development for phases II & III clinical trials and regulatory affair services
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Drug Development Solutions
When was Drug Development Solutions founded?
Drug Development Solutions was founded in 1982.
Where is Drug Development Solutions located?
Drug Development Solutions is headquartered in Ely, United Kingdom. It is registered at Ely, Cambridgeshire, United Kingdom.
Who is the current CEO of Drug Development Solutions?
Patrick Bennett is the current CEO of Drug Development Solutions.
What does Drug Development Solutions do?
Drug Development Solutions was founded in 1982 and is based in Ely, United Kingdom. Operations focus on the pharmaceutical sector, where bioanalytical testing, drug development support, and data management solutions are delivered. Services encompass regulatory compliance, analytical method development, and clinical trial data handling for clients in the life sciences industry. The company serves global pharmaceutical and biotech entities from its UK headquarters.
Who are the top competitors of Drug Development Solutions?
Drug Development Solutions's top competitors include WuXi AppTec, ANI Pharmaceuticals and Aptar.
What products or services does Drug Development Solutions offer?
Drug Development Solutions offers LC-MS/MS, Immunoassay, Flow Cytometry, and Drug Metabolism Analysis.
Who are Drug Development Solutions's investors?
Drug Development Solutions has 1 investor. Key investors include Resolian.